Skip to main content
. 2022 Dec 31;12(1):173. doi: 10.3390/cells12010173

Figure 1.

Figure 1

Clinical significance of cuproptosis regulators in ccRCC. (A) Expression levels of cuproptosis regulators between ccRCC and normal kidney tissues. (B) Methylation on promoter regions of cuproptosis regulators between ccRCC and normal kidney tissues. (CI) High expression of FDX1 (C), DLAT (D), DLD (E), PDHB (F), LIAS (G), LIPT1 (H), and PDHA1 (I) predicted longer survival in ccRCC according to Kaplan–Meier survival analyses. * p < 0.05, *** p < 0.001, **** p < 0.0001; n.s. = no significance.